Real-world Treatment and Retreatment Patterns and Outcomes in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Following Nivolumab Monotherapy in Second Line or Later in France: an I-O Optimise Analysis
Frontiers in oncology(2025)
Key words
real-world,immunotherapy,NSCLC,retreatment,rechallenge,PD-L1 expression
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined